Q6ITB5 AF NFT

Kunitz-type serine protease inhibitor microlepidin-1

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeig2qchzb42w6ulg3x3za5hzm7wjp4352npgeohub5fmu3lqae57hq/metadata.json
IPFS of structure file: 
bafybeih4uxjup4ynsj3fds7miwnzna26xmpf6arbgmenwbcnqc4i6bg25m/AF-Q6ITB5-F1-model_v2.pdb
First NFT owner address (eip-55): 
0xb8117d0344a99707ef086BEbbCC8e93baD2DC6AF
First NFT owner address (bech32): 
genesis1hqgh6q6y4xts0mcgd04mej8f8wkjm340dprn90
Current NFT ID #496796 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1

NFT id:
496796
Accession (UniProt):
Q6ITB5
Name::
Kunitz-type serine protease inhibitor microlepidin-1
Experimental Method:
Predicted structure
Sequence source:
Oxyuranus microlepidotus

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT Q6ITB5 research and analysis (ICN3D with VR)

FASTA sequences

>sp|Q6ITB5|VKT1_OXYMI Kunitz-type serine protease inhibitor microlepidin-1 OS=Oxyuranus microlepidotus OX=111177 PE=2 SV=1 MSSGGLLLLLGLLTLWEVLTPVSSKDRPDLCELPADTGPCRVGFPSFYYNPDEKKCLEFIYGGCEGNANNFITKEECESTCAA